Palantir (PLTR) Stock
Palantir Technologies (NASDAQ: PLTR) is one of the most debated stocks in the market right now — and this week it got even more controversial. Ethics disclosures released by the U.S. Office of Government Ethics revealed that President Donald Trump purchased between $247,000 and $630,000 worth of PLTR stock during Q1 2026, including at least seven transactions in March alone totaling up to $530,000. Weeks later, Trump took to Truth Social to publicly endorse the stock by its ticker symbol — the first sitting U.S. president ever to do so — writing: “Palantir Technologies (PLTR) has proven to have great war fighting capabilities and equipment. Just ask our enemies!!!” The post briefly reversed a steep intraday decline on April 10 before the stock resumed its slide. Today, PLTR trades around $132, down 25% from its 52-week high of $207.52. So what does the real story look like beneath the headlines?
What Palantir Actually Does
Palantir builds AI and data analytics platforms for two distinct customer bases: governments and enterprises. Its Gotham platform powers intelligence and defense operations — from counterterrorism to battlefield targeting. Its Foundry platform serves commercial clients as an enterprise AI operating system. Its newest product, AIP (Artificial Intelligence Platform), is the fastest-growing part of the business and connects large language models to real operational workflows. The company’s tools have been credited with accelerating submarine production for the U.S. Navy through a $448 million two-year ShipOS contract, and have reportedly been used to help identify targets in the Iran conflict — a fact that simultaneously strengthens its government moat and stirs political controversy.
The Fundamentals Are Genuinely Strong
Whatever you think of the Trump trade controversy, Palantir’s business is firing on all cylinders. Q1 2026 revenue came in at $1.63 billion, surpassing Wall Street’s expectation of $1.54 billion — its highest quarterly revenue growth rate as a public company. Net income was $870.53 million. U.S. commercial revenue surged over 130% year-over-year, demonstrating that Palantir’s growth is no longer solely dependent on government contracts. The company is guiding toward $7 billion in full-year 2026 revenue, which would represent roughly 40% year-over-year growth.
Palantir surged 134% in 2025, making it one of the top performers in the S&P 500 that year. The stock joined the S&P 500 in September 2024, and has since become one of the most widely held names among retail investors on platforms like Robinhood. CEO Alex Karp, a vocal advocate for Western military AI dominance, has positioned Palantir as the essential software layer for both the U.S. military’s modernization push and enterprise AI transformation — two of the largest spending cycles of this decade.
The Bull Case: Defense Moat Meets Commercial Acceleration
The bull case for Palantir rests on three pillars that are increasingly difficult to dispute on a fundamental basis.
The government moat is nearly impenetrable. Palantir’s classified data infrastructure, security clearances, and decade-long relationships with the CIA, NSA, Army, and allied intelligence services cannot be replicated by competitors quickly or cheaply. As the Iran conflict has demonstrated, demand for Palantir’s battlefield AI capabilities is accelerating. The $448 million Navy ShipOS contract is one of many — Palantir has been expanding aggressively into NATO allies’ defense budgets as well, despite pushback from Germany.
Commercial AIP adoption is the growth engine. U.S. commercial revenue growing 130%+ year-over-year is the number bulls keep coming back to. AIP boot camps — Palantir’s rapid deployment workshops that get enterprise customers using AI in production within days — have become a viral sales strategy. Bank of America Securities analyst Mariana Perez Mora reiterated a Buy rating and a Street-high price target of $255, citing no slowdown in revenue growth and the company’s unique ability to deploy working AI solutions rapidly. Citi raised its price target to $225 from $210 following Q1, calling the results strong.
The $7 billion 2026 revenue guide is just the beginning. If Palantir sustains 30%+ revenue growth through 2027 and 2028, the current valuation — while rich — begins to look more defensible. Bulls argue Palantir is in the early innings of a decade-long government and enterprise AI platform buildout, similar to where Salesforce was in 2010 or ServiceNow in 2015. Median analyst price target sits at $202.50, implying roughly 53% upside from current levels.
The Bear Case: Valuation, Insiders, and Political Overhang
The bear case for PLTR is almost entirely about valuation and governance — not the business itself.
The valuation is extreme by any measure. At $132 per share, PLTR trades at roughly 97x forward earnings and over 40x forward sales — making it one of the most expensive software stocks in the market. Even with 40% revenue growth, sustaining that multiple requires the market to believe growth will continue accelerating for years. Jefferies analyst Brent Thill maintains a Sell rating with a Street-low $70 price target — implying nearly 47% downside from current levels — arguing that even stellar growth cannot justify the current multiple.
Insiders are selling aggressively. Over the past six months, Palantir insiders have made 219 open-market transactions — all of them sales, zero purchases. Peter Thiel sold 2 million shares for approximately $289 million. CEO Alex Karp sold 897,914 shares for approximately $132 million. When the people who know the business best are selling 9 shares for every 1 bought by outside investors, that is a significant signal that the stock’s risk/reward is skewed to the downside at current levels.
The Trump trade is a double-edged sword. Trump’s public endorsement brought fresh retail attention and a brief price spike, but it also brought congressional scrutiny. Senator Mark Warner publicly questioned whether Trump’s post constituted market manipulation. Palantir’s work with ICE on immigration enforcement has caused Democratic candidates to return campaign contributions tied to the company. In a midterm election year, the political overhang on PLTR is not going away — and any escalation of the controversy could weigh on the stock regardless of earnings.
The stock has underperformed despite strong earnings. PLTR beat Q1 expectations meaningfully and the stock still moved lower in the days that followed. When a company consistently beats estimates and the stock falls anyway, the market is telling you that expectations are too high and the multiple too rich. That pattern — beat and drop — is one of the most reliable signals of an overvalued stock.
Price Targets: Widest Gap on Wall Street
Bull targets: Bank of America $255 • Citi $225 • Median analyst consensus $202.50
Bear / cautious targets: Jefferies $70 • Current analyst consensus Hold rating (5 Buys, 10 Holds, 2 Sells) • Benzinga Edge flags bearish price trend across short, medium and long-term periods
The gap between the Street-high target of $255 and the Street-low of $70 is one of the widest in the S&P 500 — a reflection of genuine fundamental disagreement, not just differing assumptions. That spread itself is a warning: this is a high-conviction stock in both directions, meaning the downside can be as violent as the upside.
The Bottom Line
Palantir is a genuinely exceptional business operating in two of the most important markets of this decade — defense AI and enterprise data — with a nearly unassailable government moat and a commercial growth engine that is just beginning to accelerate. The Trump trade added controversy, retail heat, and political risk simultaneously. The fundamental story is compelling. The valuation is dangerous. The insiders are selling. That combination doesn’t make PLTR a bad company — it makes it a stock where you need to be right about timing as well as fundamentals, and where the margin for error is thin.
This article is for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
About the Author
